Applied pharmacoeconomics: considerations to drive the choice of a prophylactic antithrombotic regimen
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2003
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Trials as Topic (MeSH)
- Costs and Cost Analysis (MeSH)
- Economics, Pharmaceutical (MeSH)
- Fibrinolytic Agents (MeSH)
- Humans (MeSH)
- Models, Economic (MeSH)
- Thrombosis (MeSH)